| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Original Articles |
The aim of the present study was to see whether measurements of airway hyperresponsiveness (AHR) and nitric oxide (NO) in exhaled air (ENO) either separately or in combination, could differentiate between asthmatics and healthy control subjects in a population based survey. In central Norway 8,571 adolescents participated in a large-scale epidemiological survey (Young Helseundersokelsen i Nord-Trondelag (Health Survey in North-Trondelag; HUNT). Asthmatic symptoms when exposed to pollen, pets or house-dust were reported by 7.8% (suspected asthmatics), while 56% reported no asthmatic or allergic symptoms (control subjects). From these respective groups 151 and 213 adolescents were investigated with allergy screening, measurements of exhaled and nasal NO, and methacholine challenge test. AHR (provocative dose of methacholine causing a 20% fall in forced expiratory volume in one second (PD20) <2 mg) was confirmed in 75% of the suspected asthmatics versus 25% of the control subjects, whereas 52% versus 20% had elevated levels of ENO (> or =8 parts per billion (ppb)). ENO and dose response ratio to methacholine (DRR) were positively correlated (r=0.41, p<0.001). ENO was significantly elevated in atopic versus nonatopic suspected asthmatics (11.7 ppb and 5.6 ppb respectively, p<0.001). Suspected asthmatics with both AHR and atopy had the highest levels of ENO (14.2 ppb). It is concluded that measurements of nitric oxide in exhaled air alone are not a useful tool in diagnosing asthma in population surveys, but that the combination of airway hyperresponsiveness and elevated nitric oxide in exhaled air is a very specific finding for allergic asthma. The use of dose response ratio to methacholine did not provide any additional information to the provocative dose of methacholine causing a 20% fall in forced expiratory volume in one second in this study.
This article has been cited by other articles:
|
|
 |
|
  K. G. Lim and C. Mottram The Use of Fraction of Exhaled Nitric Oxide in Pulmonary Practice Chest, May 1, 2008; 133(5): 1232 - 1242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Dressel, C. Gross, D. de la Motte, J. Sultz, R. A. Jorres, and D. Nowak Educational intervention decreases exhaled nitric oxide in farmers with occupational asthma Eur. Respir. J., September 1, 2007; 30(3): 545 - 548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Travers, S. Marsh, S. Aldington, M. Williams, P. Shirtcliffe, A. Pritchard, M. Weatherall, and R. Beasley Reference Ranges for Exhaled Nitric Oxide Derived from a Random Community Survey of Adults Am. J. Respir. Crit. Care Med., August 1, 2007; 176(3): 238 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Lund, J. Kongerud, W. Nystad, J. Boe, and J. R. Harris Genetic and environmental effects on exhaled nitric oxide and airway responsiveness in a population-based sample of twins Eur. Respir. J., February 1, 2007; 29(2): 292 - 298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D R Taylor, M W Pijnenburg, A D Smith, and J C D Jongste Exhaled nitric oxide measurements: clinical application and interpretation Thorax, September 1, 2006; 61(9): 817 - 827. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Franklin, S. M. Stick, P. N. Le Souef, J. G. Ayres, and S. W. Turner Measuring Exhaled Nitric Oxide Levels in Adults: The Importance of Atopy and Airway Responsiveness Chest, November 1, 2004; 126(5): 1540 - 1545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hjoberg, S. Shore, L. Kobzik, S. Okinaga, A. Hallock, J. Vallone, V. Subramaniam, G. T. De Sanctis, J. A. Elias, J. M. Drazen, et al. Expression of nitric oxide synthase-2 in the lungs decreases airway resistance and responsiveness J Appl Physiol, July 1, 2004; 97(1): 249 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A-C. Olin, E. Andersson, M. Andersson, G. Granung, S. Hagberg, and K. Toren Prevalence of asthma and exhaled nitric oxide are increased in bleachery workers exposed to ozone Eur. Respir. J., January 1, 2004; 23(1): 87 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P J Franklin, S W Turner, P N Le Souef, and S M Stick Exhaled nitric oxide and asthma: complex interactions between atopy, airway responsiveness, and symptoms in a community population of children Thorax, December 1, 2003; 58(12): 1048 - 1052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Dupont, M. G. Demedts, and G. M. Verleden Prospective Evaluation of the Validity of Exhaled Nitric Oxide for the Diagnosis of Asthma Chest, March 1, 2003; 123(3): 751 - 756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Members of the Task Force:, E. Baraldi, J.C. de Jongste, B. Gaston, K. Alving, P.J. Barnes, H. Bisgaard, A. Bush, C. Gaultier, H. Grasemann, et al. Measurement of exhaled nitric oxide in children, 2001: E. Baraldi and J.C. de Jongste on behalf of the Task Force Eur. Respir. J., July 1, 2002; 20(1): 223 - 237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J D Leuppi, S H Downs, S R Downie, G B Marks, and C M Salome Exhaled nitric oxide levels in atopic children: relation to specific allergic sensitisation, AHR, and respiratory symptoms Thorax, June 1, 2002; 57(6): 518 - 523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. KHARITONOV and P. J. BARNES Exhaled Markers of Pulmonary Disease Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1693 - 1722. [Full Text] [PDF]
|
|
|
|
|
|
E BARALDI and S ZANCONATO The labyrinth of asthma phenotypes and exhaled NO Thorax, May 1, 2001; 56(5): 333 - 335. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
